BMY vs DEI · P/E 17, rev $24.46B vs P/E 47, rev $507.5M
Bristol-Myers Squibb Company (BMY) versus Douglas Emmett Inc (DEI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Douglas Emmett Inc (DEI) is a reit - office company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported DEI revenue for 2026-06-30 was $507.5M. Net income was -$5.2M. DEI currently screens at market cap $3.06B and trailing P/E 47.2.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. DEI currently screens at market cap $3.06B and trailing P/E 47.2.
Not investment advice. Open the BMY and DEI stock pages for the full models.
Not investment advice.